Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | DNMT3L |
| Upstream (Parents) |
|---|
| (<<) PEBP1 → DNMT3L |
| (<<) SEC14L2 → DNMT3L |
| (<<) DYRK2 → DNMT3L |
| (<<) HAGH → DNMT3L |
| (<<) CRYAA → DNMT3L |
| (<<) IGFALS → DNMT3L |
| Downstream (Children) |
|---|
| DNMT3L → MED18 (>>) |
| DNMT3L → HCG4P6 (>>) |
| DNMT3L → ZNF814 (>>) |
| DNMT3L → SEC14L3 (>>) |
| DNMT3L → TRPC7 (>>) |
| DNMT3L → CCDC132 (>>) |
